Cargando…
Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group
In Asia, a few countries have a long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not have such groups. The process of forming national children's cancer groups is fraught with many hurdles, which va...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581612/ https://www.ncbi.nlm.nih.gov/pubmed/37656946 http://dx.doi.org/10.1200/GO.23.00153 |
_version_ | 1785122174471766016 |
---|---|
author | Li, Chi-kong Kurkure, Purna Arora, Ramandeep Singh Chen, Bow Wen Kirgizov, Kirill Okamoto, Yasuhiro Seksarn, Panya Tang, Yongmin Yoo, Keon Hee Agarwal, Bharat Chan, Godfrey C.F. Dalvi, Rashmi Hori, Hiroki Khan, Muhammad Saghir Yu, Alice Nakagawara, Akira |
author_facet | Li, Chi-kong Kurkure, Purna Arora, Ramandeep Singh Chen, Bow Wen Kirgizov, Kirill Okamoto, Yasuhiro Seksarn, Panya Tang, Yongmin Yoo, Keon Hee Agarwal, Bharat Chan, Godfrey C.F. Dalvi, Rashmi Hori, Hiroki Khan, Muhammad Saghir Yu, Alice Nakagawara, Akira |
author_sort | Li, Chi-kong |
collection | PubMed |
description | In Asia, a few countries have a long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not have such groups. The process of forming national children's cancer groups is fraught with many hurdles, which varies among the countries. One of the basic requirements for running clinical trials is an affordable health care system in which most of the children with cancer can receive the proposed treatment. The health insurance coverage for children with cancer varies from <20% to as high as 100% among Asian countries, and the operation of clinical trials must also be adjusted accordingly. Shortage of research personnel is common, including medical, nursing, research coordinators, and data managers. The establishment of the Asian Pediatric Hematology and Oncology Group aims to provide a good platform for promotion of international clinical trials in the Asian countries. |
format | Online Article Text |
id | pubmed-10581612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-105816122023-10-18 Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group Li, Chi-kong Kurkure, Purna Arora, Ramandeep Singh Chen, Bow Wen Kirgizov, Kirill Okamoto, Yasuhiro Seksarn, Panya Tang, Yongmin Yoo, Keon Hee Agarwal, Bharat Chan, Godfrey C.F. Dalvi, Rashmi Hori, Hiroki Khan, Muhammad Saghir Yu, Alice Nakagawara, Akira JCO Glob Oncol SPECIAL ARTICLES In Asia, a few countries have a long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not have such groups. The process of forming national children's cancer groups is fraught with many hurdles, which varies among the countries. One of the basic requirements for running clinical trials is an affordable health care system in which most of the children with cancer can receive the proposed treatment. The health insurance coverage for children with cancer varies from <20% to as high as 100% among Asian countries, and the operation of clinical trials must also be adjusted accordingly. Shortage of research personnel is common, including medical, nursing, research coordinators, and data managers. The establishment of the Asian Pediatric Hematology and Oncology Group aims to provide a good platform for promotion of international clinical trials in the Asian countries. Wolters Kluwer Health 2023-09-01 /pmc/articles/PMC10581612/ /pubmed/37656946 http://dx.doi.org/10.1200/GO.23.00153 Text en © 2023 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | SPECIAL ARTICLES Li, Chi-kong Kurkure, Purna Arora, Ramandeep Singh Chen, Bow Wen Kirgizov, Kirill Okamoto, Yasuhiro Seksarn, Panya Tang, Yongmin Yoo, Keon Hee Agarwal, Bharat Chan, Godfrey C.F. Dalvi, Rashmi Hori, Hiroki Khan, Muhammad Saghir Yu, Alice Nakagawara, Akira Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group |
title | Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group |
title_full | Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group |
title_fullStr | Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group |
title_full_unstemmed | Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group |
title_short | Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group |
title_sort | current challenges of asian national children's cancer study groups on behalf of asian pediatric hematology and oncology group |
topic | SPECIAL ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581612/ https://www.ncbi.nlm.nih.gov/pubmed/37656946 http://dx.doi.org/10.1200/GO.23.00153 |
work_keys_str_mv | AT lichikong currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT kurkurepurna currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT aroraramandeepsingh currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT chenbowwen currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT kirgizovkirill currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT okamotoyasuhiro currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT seksarnpanya currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT tangyongmin currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT yookeonhee currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT agarwalbharat currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT changodfreycf currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT dalvirashmi currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT horihiroki currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT khanmuhammadsaghir currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT yualice currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup AT nakagawaraakira currentchallengesofasiannationalchildrenscancerstudygroupsonbehalfofasianpediatrichematologyandoncologygroup |